-
IJMI: The screening accuracy rate is as high as 92.1
Time of Update: 2022-03-04
A research team from the Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences proposed a non-invasive screening method for cervical lesions based on transmembrane fusion cytology, HPV detection and colposcopy image examination results.
-
Say no to monopoly APIs
Time of Update: 2021-11-14
On April 15, the State Municipal Supervision Bureau again notified that a large pharmaceutical company was fined 3% of its sales in 2018, totaling 764 million yuan, for its violations of the anti-monopoly law to implement a monopoly agreement.
-
Cell: The new crown vaccine has a long way to go: a variety of COVID-19 variants evade neutralization through vaccine-induced humoral immunity
Time of Update: 2021-03-30
The mutations of the spike protein sequence of the following SARS-CoV-2 variant strains are as follows: wild type (Gray ) , D614G ( pink ) , B.
-
Difficult to compete with Asian producers European amino acid map "change face
Time of Update: 2020-07-03
the European amino acid market is also growing as interest in fortified foods grows According to a new report published by market research firm Frost and Sullivan, the European amino acid market was
-
Extraction of DHA process technology by microbial fermentation method
Time of Update: 2020-06-21
DHA (Docosahexenoic acid, 22:6 4.7.10.13.16.19, full name 22 carbon hexale acid) is an important long-chain polyunsaturated fatty acid (polyunsaturated acid, or PUFA), belonging to the s-3 series (the
-
Huabo Kaisheng Dapoxetine Hydrochloride Tablets Obtained First Domestic Approval
Time of Update: 2020-05-30
Table 1: Drug Basics Source: Company Announcement It is learned that hydrochloric acid dapositinis is a short-acting selective 5-serotonin reuptake inhibitor (SSRIs), mainly applicable to the treatm
-
Note that this kind of over 100 million Chinese patent medicine specifications need to be revised
Time of Update: 2018-07-05
[product information of chinapharma.com] on July 3, the State Food and Drug Administration issued a notice (No 42, 2018) (hereinafter referred to as the "notice") on Revising the instructions of Qingk
